Skip to main content
. 2019 Sep 16;37(34):3183–3191. doi: 10.1200/JCO.19.00917

FIG 1.

FIG 1.

Kaplan-Meier (KM) curves for progression-free survival (PFS) and generalized gamma distributions over a 20-year time horizon for the (A) gBRCAmut and (B) non-gBRCAmut cohorts, and KM curves for time with toxicity (TOX) for the (C) gBRCAmut and (D) non-gBRCAmut cohorts. gBRCAmut, germline BRCA mutation; RS, routine surveillance.